A one health framework to estimate the cost of antimicrobial resistance
Abstract Objectives/purpose The costs attributable to antimicrobial resistance (AMR) remain theoretical and largely unspecified. Current figures fail to capture the full health and economic burden caused by AMR across human, animal, and environmental health; historically many studies have considered...
Main Authors: | Chantal M. Morel, Richard A. Alm, Christine Årdal, Alessandra Bandera, Giacomo M. Bruno, Elena Carrara, Giorgio L. Colombo, Marlieke E. A. de Kraker, Sabiha Essack, Isabel Frost, Bruno Gonzalez-Zorn, Herman Goossens, Luca Guardabassi, Stephan Harbarth, Peter S. Jørgensen, Souha S. Kanj, Tomislav Kostyanev, Ramanan Laxminarayan, Finola Leonard, Gabriel Levy Hara, Marc Mendelson, Malgorzata Mikulska, Nico T. Mutters, Kevin Outterson, Jesus Rodriguez Baňo, Evelina Tacconelli, Luigia Scudeller, the GAP-ON€ network |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13756-020-00822-6 |
Similar Items
-
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
by: Marlieke E A de Kraker, et al.
Published: (2016-11-01) -
The effect of generic market entry on antibiotic prescriptions in the United States
by: Cecilia Kållberg, et al.
Published: (2021-05-01) -
Introduction and geographic availability of new antibiotics approved between 1999 and 2014.
by: Cecilia Kållberg, et al.
Published: (2018-01-01) -
How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals?
by: Jaffar A. Al-Tawfiq, et al.
Published: (2017-01-01) -
Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development
by: Ursula Theuretzbacher, et al.
Published: (2017-03-01)